Skip to the chapter Tirzepatide Finding someone to prescribe tirzepatide Chapter index - First check Find a route - Fact check Know the medicine - Question list Prepare for care - Cost checklist Untangle payment First check · Finding care # Tirzepatide providers. Find your way to care. A plain-language guide to finding a doctor, checking a clinic and preparing questions about tirzepatide. Start with - The medicine - The licence - The follow-up A question is a good beginning. There is room to ask. Looking for someone to talk to about tirzepatide? Start with your usual doctor, an in-person clinic or an online visit. Ask who will treat you, which medicine they offer and how to reach them afterward. Explore the search routes ↓ ## What is tirzepatide? Tirzepatide is a medicine that copies two of the body’s natural signals for hunger and blood sugar. The U.S. Food and Drug Administration (FDA) checks medicines before it approves them for specific health problems. As of September 2026, tirzepatide (Mounjaro, Zepbound) has FDA approval for specific uses. The brands share an ingredient, but their approved uses differ. Source: Zepbound label, held by the National Library of Medicine ↗ Check what the medicine names mean → Choose a starting point ## Ways to begin the search Pick the kind of conversation you want. Keep the same questions close whichever route you choose. A familiar starting point ### Ask your usual doctor or nurse Bring up your goal at a visit, or ask how to arrange a separate discussion. A direct question can open the door without making a choice about treatment. Can we talk about tirzepatide, or can you help me find someone who provides this care? Ask whether that person can check your health, who else they might suggest seeing, and how your existing care would fit in. A route can start with a conversation. Close to home ### Look into an in-person clinic Ask for the name and licence details of the person who would assess you. Make a note of who is giving the answer. The Federation of State Medical Boards directory links to state medical boards, where a doctor’s licence can be checked. These state offices keep records of a doctor’s licence, the state’s permission to practise medicine. The records can show whether the doctor has a current licence and whether the board has ordered penalties for problems with their work. A licence record without public action cannot show the quality of the care. Source and lookup route: state medical board directory ↗ If someone who is not a doctor will treat you, ask which state board keeps that person’s licence details and how to find the record. Keep a small search note - Full name of the person treating you - State board and licence record - How to ask a follow-up question From where you are ### Consider an online or phone visit A visit with a doctor or another health professional through video, a phone call or online messages is called telehealth. As of September 2026, your health professional needs a licence or other legal permission for the state you are in at visit time. State rules and exceptions vary, so check the rule for your location. Source: U.S. health department guidance on licences ↗ Ask who reviews your health history and how to raise questions. Also ask how any needed exam or test in person would be set up. Make space for a real conversation. ## Keep the pharmacy in the picture Some pharmacies mix a medicine for a particular patient instead of dispensing a finished medicine from a drug company; this is called compounding. The FDA warns that people getting compounded medicine online may not know which pharmacy actually prepared it. The FDA’s lookup page links to state offices that keep pharmacy licence records. Source and lookup route: FDA’s state pharmacy searches ↗ Which pharmacy would make or fill this prescription, and how can I check its licence? Carry this forward ## Leave the search with a name, a licence check and a way to ask again. Next chapter: check the medicine → This guide helps you find the next question on the way to tirzepatide care; it is no clinic and sells no medicine. Back to the first check Read this chapter as text Full text edition Room for questions. Time to think. Skip to the chapter Tirzepatide Finding someone to prescribe tirzepatide Chapter index - First check Find a route - Fact check Know the medicine - Question list Prepare for care - Cost checklist Untangle payment Fact check · The medicine # Know what the medicine claim means. Start with the exact medicine name. Then check what the source actually says about it. Your medicine check - Name the medicine - Check approved uses and pharmacy-made versions - Read the source ## Same ingredient. Different approved uses. The U.S. Food and Drug Administration (FDA) checks medicines before it approves them for specific health problems. As of September 2026, tirzepatide (Mounjaro) is approved for type 2 diabetes, a condition involving high blood sugar. Its label, the official instructions and warnings, also covers reducing major heart risks in adults with type 2 diabetes who are at high risk. Mounjaro’s label does not approve it for weight loss (as of September 2026). Source: Mounjaro label, National Library of Medicine ↗ Tirzepatide (Zepbound) has approval for adult weight management alongside diet and physical activity, as of September 2026. That use covers adults with obesity, or with overweight plus a health problem linked to weight. As of September 2026, it also covers adults with obesity whose obstructive sleep apnea is moderate to severe. Obstructive sleep apnea means repeated blocks in breathing during sleep. Source: Zepbound label, National Library of Medicine ↗ Pause at this word ## What does “compounded” mean? Compounding means a pharmacist or doctor mixes a medicine for a particular patient instead of dispensing a ready-made medicine from a drug company. As of September 2026, compounded medicines are not approved by the FDA. Before these medicines are sold, the FDA does not review how safe they are, their quality or how well they work. As of September 2026, the FDA says compounding can help a person with medical needs an approved medicine cannot meet. For example, a pharmacy might leave out a dye that a patient is allergic to. Source: FDA’s questions and answers on compounding ↗ Read the exact claim, then its source. ## The shortage story has changed As of September 2026, the FDA no longer listed tirzepatide as a medicine in short supply across the country. The FDA’s extra time for pharmacies to stop tirzepatide copies that broke shortage-related rules had ended by September 2026. A medicine does not join the national shortage list simply because one pharmacy has run out. Source: FDA’s dated compounding policy updates ↗ As of September 2026, ordinary pharmacies cannot regularly make tirzepatide that is essentially the same as a medicine already sold by a drug company. A pharmacy may change a named patient’s medicine if the person prescribing it finds that the alteration makes a significant difference for that patient. This means a meaningful difference for the patient, not just a lower price, as of September 2026. A state-licensed pharmacy and a valid prescription for that patient are also required. Even with a medical need, the preparation must meet all the legal requirements for pharmacy-made medicines. Source: federal law on pharmacy-made copies ↗ Why can’t an approved medicine meet my needs, and what rules allow this pharmacy to make my prescription? A claim worth opening ## Check a common mix-up Open a question to reveal what the evidence says. How does pharmacy-made tirzepatide differ from a brand-name copy? + An FDA-approved copy of a brand-name medicine is called a generic. As of September 2026, tirzepatide has no approved generic, and a pharmacy-made version is not one. Source: FDA drug application records ↗ Does a small medicine bottle, called a vial, mean it is pharmacy-made? + No. As of September 2026, tirzepatide (Zepbound) also comes in FDA-approved small bottles called vials. Check who made the medicine; the bottle alone cannot tell you. Source: Zepbound label, National Library of Medicine ↗ Does “research use” make it a treatment option? + FDA warns against unapproved tirzepatide sold for human use under research labels because its quality is unknown and it may cause harm (as of September 2026). Source: FDA’s concerns about weight medicines outside the approval process ↗ ## What did a weight trial find? With tirzepatide, the SURMOUNT-1 study recorded an average loss of about 15% to 21% of starting weight over 72 weeks. These results came from adults without diabetes. The amount of medicine in the study’s shots affected the average weight loss. People given shots without the study medicine lost about 3% of their starting weight on average. The drug maker supported the trial, which included regular visits and help with daily habits. A trial average is not a promised result for an individual. Source: weight trial published in the New England Journal of Medicine ↗ Carry this forward ## Know the product before comparing the claims. Next chapter: prepare your questions → This guide helps you find the next question on the way to tirzepatide care; it is no clinic and sells no medicine. Back to the first check Read this chapter as text Full text edition Room for questions. Time to think. Skip to the chapter Tirzepatide Finding someone to prescribe tirzepatide Chapter index - First check Find a route - Fact check Know the medicine - Question list Prepare for care - Cost checklist Untangle payment Question list · The visit # Bring your questions. Leave with a plan. A visit is a place to talk through your goal, your health history and what happens next. It is fine to come to the visit before choosing a treatment. Leave a little space for questions. ## What getting care involves Ask how the first health check works. Is it a conversation, an online exchange, or an in-person visit? Ask what happens after you share your health history. Discuss the plan for a prescription, the pharmacy that would fill it and the follow-up. As of September 2026, national guidance from medical boards says an online medicine menu cannot take the place of a real check of your health. Under that guidance, you must have a way to put your own follow-up questions to the person providing your care. This guidance recommends how visits should work; your state sets the legal rules the person treating you must follow. Source: Federation of State Medical Boards prescribing guidance ↗ Who will check my health, and how can I ask that person questions? ## Bring the parts of your history that matter The medicine’s official instructions and warnings, called its label, list these topics to discuss, as of September 2026. - Whether you or a relative has had medullary thyroid cancer (MTC), a rare thyroid cancer. - Whether you have MEN 2, the name of a rare condition that can be passed from a parent to a child. - Past pancreas or gallbladder problems, very slow stomach emptying, or diabetes-related eye problems. - Serious allergies, pregnancy plans, birth control pills, other diabetes medicines and planned surgery. Source: Zepbound label, National Library of Medicine ↗ Ask relatives about the names above, or bring family medical records that mention them. If you do not know, say so at the visit. Bring a list of the medicines you take and any questions you do not want to forget. Ask which tests or records, if any, are needed for your health check. ## Talk about the difficult parts, too Nausea (feeling sick), vomiting, diarrhea and constipation were common problems in Zepbound’s weight trials. The Zepbound label checked September 2026 warns that some stomach problems can be severe and fluid loss can harm the kidneys. Source: Zepbound label, National Library of Medicine ↗ Both tirzepatide labels carry a boxed warning, their strongest type of warning, about thyroid tumors found in rats. Whether tirzepatide causes those tumors in people is unknown. The labels say this medicine must not be used if you or a relative has had MTC, the thyroid cancer named above. It must also not be used if you have the inherited condition MEN 2 or a known serious allergy to the medicine or its ingredients. Source: Mounjaro label, National Library of Medicine ↗ Tirzepatide can affect how well birth control pills work, according to the Zepbound label checked September 2026. Ask whoever writes your prescription to explain how the label’s instructions for extra birth control apply to you. Source: Zepbound label, National Library of Medicine ↗ A note to take along ## Questions for the visit and the follow-up - Which medicine are we discussing, and will it come in an injection pen or a small bottle? - What in my health history affects whether this is an option? - What tests or in-person checks might be needed? - Who can I reach about symptoms between visits? - How will we review whether the treatment is helping? - What would the plan be if I needed to stop? - What costs continue between visits? Copy the questions into a note, or bring this page. Add the question that is worrying you most. ## When an allergic reaction needs urgent help Possible signs of a severe allergic reaction include trouble with breathing or swallowing and swelling in the face or tongue. For severe allergy symptoms, MedlinePlus says to call 911 or seek help at the closest emergency room. Source: MedlinePlus guidance on severe allergic reactions ↗ Carry this forward ## A useful plan names the next contact, the next check and the ongoing cost. Next chapter: check the payment plan → This guide helps you find the next question on the way to tirzepatide care; it is no clinic and sells no medicine. Back to the first check Read this chapter as text Full text edition Room for questions. Time to think. Skip to the chapter Tirzepatide Finding someone to prescribe tirzepatide Chapter index - First check Find a route - Fact check Know the medicine - Question list Prepare for care - Cost checklist Untangle payment Cost checklist · Payment # Ask for the whole cost. Then compare. Ask for a written breakdown of the medicine, visits, tests and follow-up. Write beside each price whether you would pay it yourself or use insurance. A small note can untangle a big bill. ## What does the headline price cover? Medicine Which medicine, in an injection pen or a small bottle, and how much is included? Care Is the health check billed per visit or as an ongoing membership? Tests and follow-up Which checks and messages are included? What could be billed separately? Commitment Must I pay in advance, keep getting refills or agree to a longer contract? What would I pay after an introductory offer ends, and how do I cancel? ## A starting cash price is only a starting point As of September 26, 2026, the government price page listed tirzepatide (Zepbound) from $299 per month. That starting figure applied to the lowest strength, meaning the smallest amount of medicine per injection; it was not a price for every prescription. A drug maker’s published figure is its list price; a cash offer or an insurance copay means something different. The patient’s share of a bill covered by insurance is called a copay. Source: U.S. government prescription price directory ↗ Ask for the price for your exact prescription, both with insurance and if you pay yourself. Write down what is included and when the offer ends. For people using Medicare ## A temporary Medicare payment program Part D means Medicare prescription-drug coverage. As of September 2026, qualifying Part D members pay a $50 monthly copay under the temporary Medicare GLP-1 Bridge program. The September 2026 check gives a scheduled start of July 1, 2026 and an end of December 31, 2027. Source: Medicare’s Bridge program, Centers for Medicare & Medicaid Services ↗ For tirzepatide (Zepbound), Bridge covers only the KwikPen, an injection pen holding several doses, as of September 2026. Single-dose pens, used for one injection, and vials, small medicine bottles, are excluded from Bridge, as of September 2026. To apply, you need a prescription and program approval, and must be at least 18, as of September 2026. Your coverage, as of September 2026, must be either a separate drug plan under Part D or an eligible Medicare Advantage plan that includes medicines. As of September 2026, the health rules use body mass index (BMI), a figure calculated from height and weight. - One way to meet the weight rule is a BMI of 35 or more. - With a BMI of 30 or more, certain heart failure, hard-to-control high blood pressure or kidney disease can qualify. - With a BMI of 27 or more, qualifying problems include a previous heart attack, a previous stroke, prediabetes, or disease of the blood vessels in the arms or legs with symptoms. Prediabetes means sugar in the blood is higher than normal, but has not reached the level for diabetes. Ask whoever writes your prescription to compare your health records with the precise health rules. Ask your plan whether its type of coverage is included. Source: Medicare’s product and eligibility rules ↗ Ask the plan - Do I qualify for Bridge? - Is this medicine and its injection pen included? - What approval must the person writing my prescription request? ## Check what that payment counts toward As of September 2026, the $50 you pay for Bridge does not go toward the annual limit on your medicine spending through normal Part D coverage. So these payments do not bring you closer to that cap, even though the money comes out of your pocket. You cannot use a coupon to reduce a prescription’s $50 Bridge payment, as of September 2026. Source: Medicare’s consumer guide to weight-loss drug coverage ↗ The usual Part D insurance process is separate from Bridge’s temporary $50 program, as of September 2026. Medicare’s usual Part D rules may cover tirzepatide (Mounjaro) when it is prescribed for type 2 diabetes, as of September 2026. Zepbound may be covered, as of September 2026, for adults with obesity whose obstructive sleep apnea is moderate to severe. This means repeated breathing blockages during sleep; the severity and weight requirements matter. People with type 2 diabetes or this sleep condition must check usual Part D coverage rather than Bridge, as of September 2026. Possible coverage does not guarantee that your plan will pay; check its list of covered medicines and approval rules. Prior authorization means the plan must approve payment before the pharmacy fills the prescription. Source: Medicare’s guidance on usual prescription coverage ↗ ## Payment questions for any care route - Is this price for paying myself or using insurance? - Will the plan cover this medicine for the reason it is being prescribed? - What happens to the cost if the plan declines payment? - Can I see the refill and cancellation terms in writing? - What amount would I pay for ongoing care as well as the medicine? Carry this forward ## Keep the medicine, how you will pay and the full bill together in the same note. Return to the questions for your visit → This guide helps you find the next question on the way to tirzepatide care; it is no clinic and sells no medicine. Back to the first check Read this chapter as text Full text edition Room for questions. Time to think.